Thus, given the diverse nature of the relationship between CDKN2A/p16 and fibrosis in different tissues, and the lack of definitive consensus, investigating this relationship in the pancreas, including pancreatic cancer, is essential. Here, CDKN2A is linked to familial pancreatic carcinoma.